NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Researchers at Aarhus University release new data on breast cancer



January 22nd, 2009

"Epidemiological studies imply an association between circulating IGF1 and breast cancer. whereas the role of IGF2. which also acts oil the IGF1 receptor, is less settled. This study investigates the association between IGF2 and breast cancer in patients with localized disease," scientists in Aarhus, Denmark report.

"The participants were women with well-characterized. early stage. localized breast cancer (n = 43) and matched healthy women (n=38), from whom fasting serum levels of IGF-related peptides were measured. In patients. mean Free IGF2 was increased (+ 57%. P<0.001), in spite of reduced total IGF2 levels (- 12%. P = 0.003) when Compared with controls....


Source: Women's Health Weekly (2009-01-22)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login